semaglutide subcutaneous or intramuscular Injecting Semaglutide: A Guide to Injection Sites and Technique Semaglutide Injection Site: Muscle vs.

Learn more on ClinicalTrials.gov: Be part of the team thats answering some of the biggest questions in healthcare

Boehringer Ingelheim describes it as a dual glucagon/GLP1 receptor agonist that has the potential to address obesity while also supporting liver function, a key regulator of metabolic health. The company links the waistcircumference reduction in SYNCHRONIZE1 to effects on visceral fat, noting that excess visceral fat, particularly abdominal, is a known contributor to metabolic dysfunction and closely connected to impaired liver function

Patients should be monitored for tolerability during dose titration, and bile duct stones remain a rare possibility even without a gallbladder

If you started with medical weight loss and you're not reaching your goals, we'll have an honest conversation about why